Marvel Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Mjbiopharm: trust score, financial health, credit view, compliance, directors, growth and distress signals - g…

1999-03-22 Mumbai, Maharashtra Strike Off Unlisted Active Compliant
Share
Connect MCP
ML Marvel Life Sciences Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Mjbiopharm — 360° Intelligence Report

Generated from MCA filings & public records
45/100
Trust Score
Caution Indicated

Mjbiopharm is assessed as Caution Indicated with a Trust Score of 45/100. Mjbiopharm is a private limited indian non-government company incorporated in 1999, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 13 Aug 2026 from the latest processed filings. Marvel Life Sciences Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
45/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
20/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
20/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 30/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Last balance sheet is for Mar 2020 - filings overdue.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
AMOL JASHVANT SHAH 01234567 Director 01/04/2018 6 yrs Approved
DHAVAL VIPIN VASHI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
M. J. Biopharm Private Limited
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
M. J. Biopharm Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 20
Growth signals & trust indicators
Operating for 27+ years.
Distress signals & risk flags
Losses deepening year-on-year.
Negative net worth.
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (30/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence32/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment36/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view38/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 8 events
28 Sep 2020
Last AGM held
Annual general meeting
31 Mar 2020
Latest balance sheet
Filed with ROC
13 Oct 2016
Director ceased
ASHOK SHAH
23 Sep 2016
Director ceased
DHAVAL VIPIN VASHI
10 Jul 2015
Director appointed
DHAVAL VIPIN VASHI (Director)
Director ceased
JASHVANT MANSUKHLAL SHAH
01 Jan 2000
Director appointed
AMOL JASHVANT SHAH (Director)
22 Mar 1999
Incorporated
Registered with Roc Mumbai
10

Key Observations

Auto-generated from the data above
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Maa Bijasani Life Sciences Private Limited U24239MH2006PTC165879 Shirpur, Maharashtra, India
B.A.B. Agencies Private Limited U51109WB1987PTC042643 Kolkata, West Bengal, India
Risty Healthcare Private Limited U33100OR2019PTC030477 Bhubaneshwar, Orissa, India
Jagosh Pharma Private Limited U51909MH2018PTC306398 Kamothe, Maharashtra, India
Lal Genchem Limited U74999DL2018PLC328149 Delhi, Delhi, India
Provectus Life Sciences Private Limited U24233UP2015PTC067993 Ghaziabad, Uttar Pradesh, India
Yonutra Private Limited U15116MH2017PTC291015 Taloja Majkur Raigard, Maharashtra, India
Tsalach Products Private Limited U74999HR2018PTC075667 Faridabad, Haryana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Mjbiopharm before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Mjbiopharm: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 50/100, margin trends, ownership structure and peer set for Mjbiopharm - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 45/100, distress signals and MSME payment-delay disclosures - know whether Mjbiopharm pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Mjbiopharm - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Mjbiopharm an active company?

Mjbiopharm has MCA status “Strike Off” with a compliance score of 30/100 (Caution Indicated).

Is Mjbiopharm financially healthy?

Mjbiopharm has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Mjbiopharm?

Its overall Trust Score is 45/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Mjbiopharm?

The ultimate holding entity is M. J. Biopharm Private Limited. 2 active director(s) are on record.

Does Mjbiopharm have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Mjbiopharm up to date with its ROC filings?

Last balance sheet is for Mar 2020 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).

Is it risky to lend to Mjbiopharm?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.